Nina de Jong

Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection: a prospective cohort study

N. Kootstra, M. V. van Gils, Annelou van der Veen, 2022, BMC Medicine.

A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern

M. Prins, N. Kootstra, R. Sanders, 2021, Cell Reports Medicine.

Development of broadly reactive influenza vaccines by targeting the conserved regions of the hemagglutinin stem and head domains

M. V. van Gils, D. Eggink, Nina de Jong, 2020, Expert review of vaccines.